Item 8.01 Other Events.
On
A copy of the Plan of Dissolution is filed as Exhibit 2.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Cautionary Information Regarding Trading in the Company's Securities
The Company cautions that trading in the Company's securities is highly speculative and poses substantial risks. Trading prices for the Company's securities may bear little or no relationship to the actual value realized, if any, by holders of the Company's securities. Accordingly, the Company urges extreme caution with respect to existing and future investments in its securities.
Additional Information and Where to Find It
Rubius will file with the
Certain Information Concerning Participants
Rubius and its directors and executive officers may be deemed to be participants
in the solicitation of proxies from stockholders of the Company in connection
with the planned dissolution. Information about the persons who may be
considered to be participants in the solicitation of the Company's stockholders
in connection with its planned dissolution, and any interest they have in the
planned dissolution, will be set forth in the definitive proxy statement when it
is filed with the
Forward Looking Statements
Certain statements in this report constitute "forward-looking statements" of the
Company within the meaning of applicable laws and regulations and constitute
"forward-looking information" within the meaning of applicable securities laws.
Any statements contained herein which do not describe historical facts,
including statements regarding the Company's Plan of Liquidation and the related
Special Meeting are forward-looking statements which involve risks and
uncertainties that could cause actual results to differ materially from those
discussed in such forward-looking statements. Such risks and uncertainties
include, among others, the possibility that the Company's stockholders will not
realize any value in the Company's shares or that the Plan of Liquidation will
not be able to be completed in a timely manner, or at all, as well as those
risks identified in the Company's filings with the Commission, including under
the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the
year-ended
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 2.1 Plan of Dissolution ofRubius Therapeutics, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source